Savara Inc (SVRA)
4.48
-0.24
(-5.08%)
USD |
NASDAQ |
May 17, 16:00
4.465
-0.02
(-0.33%)
After-Hours: 20:00
Savara Price to Book Value: 5.080 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 5.080 |
| May 16, 2024 | 5.352 |
| May 15, 2024 | 5.477 |
| May 14, 2024 | 5.454 |
| May 13, 2024 | 5.205 |
| May 10, 2024 | 5.279 |
| May 09, 2024 | 5.749 |
| May 08, 2024 | 5.658 |
| May 07, 2024 | 5.964 |
| May 06, 2024 | 5.613 |
| May 03, 2024 | 5.335 |
| May 02, 2024 | 5.307 |
| May 01, 2024 | 5.613 |
| April 30, 2024 | 5.193 |
| April 29, 2024 | 5.227 |
| April 26, 2024 | 5.000 |
| April 25, 2024 | 5.046 |
| April 24, 2024 | 4.808 |
| April 23, 2024 | 5.318 |
| April 22, 2024 | 5.329 |
| April 19, 2024 | 5.454 |
| April 18, 2024 | 5.431 |
| April 17, 2024 | 5.624 |
| April 16, 2024 | 5.851 |
| April 15, 2024 | 5.715 |
| Date | Value |
|---|---|
| April 12, 2024 | 5.749 |
| April 11, 2024 | 6.055 |
| April 10, 2024 | 5.375 |
| April 09, 2024 | 5.556 |
| April 08, 2024 | 5.307 |
| April 05, 2024 | 5.42 |
| April 04, 2024 | 5.227 |
| April 03, 2024 | 5.431 |
| April 02, 2024 | 5.295 |
| April 01, 2024 | 5.488 |
| March 28, 2024 | 4.901 |
| March 27, 2024 | 4.773 |
| March 26, 2024 | 4.832 |
| March 25, 2024 | 4.744 |
| March 22, 2024 | 4.724 |
| March 21, 2024 | 4.812 |
| March 20, 2024 | 4.812 |
| March 19, 2024 | 4.783 |
| March 18, 2024 | 4.635 |
| March 15, 2024 | 4.635 |
| March 14, 2024 | 4.586 |
| March 13, 2024 | 4.812 |
| March 12, 2024 | 4.842 |
| March 11, 2024 | 4.832 |
| March 08, 2024 | 5.216 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2747
Minimum
Nov 14 2019
6.055
Maximum
Apr 11 2024
1.930
Average
1.275
Median
Mar 12 2020
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | 20.44 |
| iBio Inc | 0.7501 |
| Theriva Biologics Inc | 0.204 |
| Oragenics Inc | 6.627 |
Price to Book Value Related Metrics
| Price | 4.48 |
| Earnings Yield | -8.26% |
| Market Cap | 619.09M |